Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free SCLXW Stock Alerts

Scilex (SCLXW) Competitors

Scilex logo
$0.12 +0.02 (+23.71%)
As of 09/9/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SCLXW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Scilex stock or one of its competitors? Scilex's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Scilex compare to 60 Degrees Pharmaceuticals?

Scilex (NASDAQ:SCLXW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$31.61MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Scilex. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Scilex. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Scilex's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Scilex Neutral
60 Degrees Pharmaceuticals Very Positive

Summary

60 Degrees Pharmaceuticals beats Scilex on 2 of the 3 factors compared between the two stocks.

How does Scilex compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Scilex (NASDAQ:SCLXW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Scilex N/A N/A N/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Scilex'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Scilex Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Scilex$31.61MN/AN/AN/AN/A

Summary

Biofrontera beats Scilex on 1 of the 1 factors compared between the two stocks.

How does Scilex compare to Cingulate?

Scilex (NASDAQ:SCLXW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, Scilex's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Scilex Neutral
Cingulate Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$31.61MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

Scilex beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Scilex compare to Clever Leaves?

Scilex (NASDAQ:SCLXW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Clever Leaves N/A N/A N/A

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Scilex's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Scilex Neutral
Clever Leaves Neutral

Scilex has higher revenue and earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$31.61MN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

Summary

Clever Leaves beats Scilex on 2 of the 3 factors compared between the two stocks.

How does Scilex compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and Scilex (NASDAQ:SCLXW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Scilex$31.61MN/AN/AN/AN/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Scilex'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Scilex Neutral

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Scilex N/A N/A N/A

Summary

Scilex beats Comera Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLXW vs. The Competition

Export
MetricScilexPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.51B$7.22B$12.88B
Dividend YieldN/A2.61%2.55%9.95%
P/E RatioN/A794.76271.7825.29
Price / SalesN/A955.42715.56118.14
Price / CashN/A91.3177.5552.32
Price / BookN/A10.6210.506.26
Net IncomeN/A$2.82B$3.48B$357.86M
7 Day Performance-4.64%-1.93%-1.14%-0.59%
1 Month PerformanceN/A3.14%2.04%-1.07%
1 Year Performance-71.95%5.72%21.91%11.31%

Scilex Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLXW
Scilex
N/A$0.12
+18.6%		N/A-74.6%$0.00$31.61MN/A105
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-48.1%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
-10.0%		N/A-82.9%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
+1.1%		N/A-87.8%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/A-33.3%$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SCLXW) was last updated on 9/10/2026 by MarketBeat.com Staff.
From Our Partners
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
Jon Najarian's #1 Energy Trade for 2026
Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...
Banyan Hill Publishing | Sponsoredtc pixel
Gold majors have a big problem
Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...
Golden Portfolio | Sponsoredtc pixel